Rx Pricing Attacks Fail In Key House Races; Medicare Rx Vote Protects GOP
Executive Summary
The House leadership is unlikely to change its approach to Medicare prescription drug coverage and pharmaceutical pricing following the Republican victories in the mid-term elections Nov. 5
You may also be interested in...
House Committee Assignments: Little Shake-Up In The New Make-Up
Members of the House Energy & Commerce and Ways & Means Committees in the 108th Congress are likely to stay the course set by their predecessors regarding prescription drug issues
House Committee Assignments: Little Shake-Up In The New Make-Up
Members of the House Energy & Commerce and Ways & Means Committees in the 108th Congress are likely to stay the course set by their predecessors regarding prescription drug issues
Generic Drug Reform Outlook: Medicare Rx Bill May Be Best Vehicle
The best opportunity to push Waxman/Hatch reforms in the next Congress will likely be in the context of a Medicare prescription drug benefit bill